Ambria Capital
Crossover fundSan Juan PR · Seed–Series C · 3 people tracked
Find your way into Ambria Capital
Sign up to see every warm intro you have to Ambria Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ambria Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Ambria Capital invests across emerging public and private market opportunities in agriculture, consumer, healthcare, and technology. The firm combines rigorous analytical frameworks with an extensive network of industry relationships to identify and connect market leaders with growth opportunities in small-cap markets.
Source: firm website, verified Aug 5, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 4 of 5 portfolio companiesAI & Machine Learning ×2Biotech ×2Healthtech ×2AgTech ×1IoT ×1Mental Health ×1
HQs:United States×4India×1
Investments · 5 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12021 · 35 dated
Fyllo builds IoT sensor devices, hyper-local weather forecasting, and crop-specific agronomy models that provide data-driven irrigation, fertigation, and disease-prediction recommendations to farmers.
AgTechAI & Machine LearningIoTBengaluru, IN
Sudhanshu Rai(Co-Founder)inSumit Sheoran(Co-Founder)in
Co-investors100XCapria VenturesIndia QuotientTitan CapitalArcadian CapitalEminence Ventures+2 more
Miami, US
Mark Goldhar(Executive Officer, Director)Cory Jones(Executive Officer, Director)inRay Harari(Director)Josh Neilly(Director)Cody Shandraw(Executive Officer, Director)in
BoardKatelin Holloway(Director)
Co-investorsPhyto Partners
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(CEO)inTom Ray(Founder)inTegan Johnson(Director of Operations)
BoardRand Hindi(Director)in
Co-investorsARA NEA Ventures (Brand: Dmz.Xyz)Blast.ClubEmpath VenturesGaingelsImmeasurableInitialized Capital+14 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Mycrodose TherapeuticsWeSana Health
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Ambria Capital made?
- Ambria Capital has 5 tracked investments, including 1 dated in the last 24 months.
- What stage does Ambria Capital invest at?
- Ambria Capital invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Ambria Capital focus on?
- Ambria Capital focuses on AgTech, AI & Machine Learning, Consumer, Healthtech.
- Where is Ambria Capital located?
- Ambria Capital is headquartered in San Juan PR, US.
Media · Podcasts & interviews
featuring the teamConsolidation in Psychedelics Industry in 2022? Cody Shandraw, Managing Partner @ Ambria Capital
Microdose | Psychedelics Business Guide · Cody Shandraw
Co-investors · 2
XEIA Venture Partners is a venture capital firm that invests in early-stage companies, with a thematic focus on health, wellbeing and performance ('Human 3'). It closed a first fund and did a first close on a second fund.
Four Acres is an early-stage venture capital fund founded by native New Yorkers, focused on software-first technology companies.
Firms observed investing alongside Ambria Capital, from public investor directories. Shared companies are the overlap with Ambria Capital's recorded portfolio.
Similar investors
Collaborative Fund is a venture capital firm that backs entrepreneurs building category- and culture-defining brands, products, and services across consumer, health, energy, and access-to-capital themes.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Partech is a global venture capital firm supporting founders across multiple continents and investment stages through dedicated teams and funds.
This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).
Valor Capital Group is a cross-border venture fund connecting the US, Latin American, and global technology markets, investing in consumer internet and enterprise software companies.












__Twitter.png)


